Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.07
Performance (%)
9.03%
Price
19.06.26
€83.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 9.03%. This prediction currently runs until 17.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 9.868% | 9.868% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.00
06.05.26
06.05.26
€116.89
06.05.27
06.05.27
4.32%
19.06.26
19.06.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€84.50
18.02.26
18.02.26
-
18.02.27
18.02.27
-1.18%
19.06.26
19.06.26